Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasper Tromp

Showing results (171-180 of 200) with videos related to

Pageof 20
Sort By:
BMJ Global Health|January 29, 2025
Starfield's 4Cs of NCD management in primary healthcare: a conceptual framework development from a case study of 19 countriesChuan De Foo, Krishaa Logan, Elliot Eu, et al.
Diabetes, Obesity & Metabolism|June 13, 2025
The effect of sodium-glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DMRan Guo, Ambarish Pandey, Chanchal Chandramouli, et al.
BMJ (Clinical Research Ed.)|March 24, 2021
Age dependent associations of risk factors with heart failure: pooled population based cohort studyJasper Tromp, Samantha M A Paniagua, Emily S Lau, et al.
JACC. Asia|March 6, 2023
Incidence, Clinical Correlates, and Prognostic Impact of Dementia in Heart Failure: A Population-Based Cohort StudyQing-Wen Ren, Tiew-Hwa Katherine Teng, Yi-Kei Tse, et al.
European Journal of Heart Failure|January 13, 2018
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHFJoost C Beusekamp, Jasper Tromp, Haye H van der Wal, et al.
The American Journal of Cardiology|November 9, 2016
Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)Jasper Tromp, Jozine M Ter Maaten, Kevin Damman, et al.
The Lancet Regional Health. Western Pacific|June 19, 2026
Systematic review of cardiovascular care delivery across health systems in the Asia-Pacific: a regional roadmap for strengthening cardiovascular careNicholas Ws Chew, Gwyneth Kong, F Aaysha Cader, et al.
European Journal of Heart Failure|May 16, 2019
The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF studyGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|August 17, 2018
Heart failure with preserved ejection fraction in AsiaJasper Tromp, Tiew-Hwa Teng, Wan Ting Tay, et al.
European Journal of Heart Failure|June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registriesWouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
Pageof 20

Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
BMJ Global Health|January 29, 2025
Starfield's 4Cs of NCD management in primary healthcare: a conceptual framework development from a case study of 19 countriesChuan De Foo, Krishaa Logan, Elliot Eu, et al.
Diabetes, Obesity & Metabolism|June 13, 2025
The effect of sodium-glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DMRan Guo, Ambarish Pandey, Chanchal Chandramouli, et al.
BMJ (Clinical Research Ed.)|March 24, 2021
Age dependent associations of risk factors with heart failure: pooled population based cohort studyJasper Tromp, Samantha M A Paniagua, Emily S Lau, et al.
JACC. Asia|March 6, 2023
Incidence, Clinical Correlates, and Prognostic Impact of Dementia in Heart Failure: A Population-Based Cohort StudyQing-Wen Ren, Tiew-Hwa Katherine Teng, Yi-Kei Tse, et al.
European Journal of Heart Failure|January 13, 2018
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHFJoost C Beusekamp, Jasper Tromp, Haye H van der Wal, et al.
The American Journal of Cardiology|November 9, 2016
Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)Jasper Tromp, Jozine M Ter Maaten, Kevin Damman, et al.
The Lancet Regional Health. Western Pacific|June 19, 2026
Systematic review of cardiovascular care delivery across health systems in the Asia-Pacific: a regional roadmap for strengthening cardiovascular careNicholas Ws Chew, Gwyneth Kong, F Aaysha Cader, et al.
European Journal of Heart Failure|May 16, 2019
The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF studyGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|August 17, 2018
Heart failure with preserved ejection fraction in AsiaJasper Tromp, Tiew-Hwa Teng, Wan Ting Tay, et al.
European Journal of Heart Failure|June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registriesWouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
Pageof 20